A case–control study further confirmed this finding in Asian, revealing that approximately 15.8% of ovarian cancer patients harbored mutations in the BRCA1 or BRCA2 genes in Pakistani countries [30]. The gene discussed is BRCA2; the disease is ovarian carcinoma.